Should I stop treatment for Melanoma and focus on quality of life

Deciding Between Treatment and Quality of Life: An Important Conversation

This is one of the most personal and significant decisions you may face. I want to help you think through this carefully, but I need to be clear: this decision requires a detailed conversation with your oncology team who knows your complete medical situation.

Why This Decision Is Complex

The choice between continuing treatment and focusing on quality of life depends on many factors that are unique to you:

• Your specific melanoma stage and type (early stage vs. metastatic/stage 4)
• How your cancer is responding to current treatment
• Your overall health and ability to tolerate treatment side effects
• Your personal values about quantity vs. quality of remaining time
• Available treatment options specific to your situation
• Your symptoms and side effects from current therapy

What the Guidelines Say About Your Options

According to the NCCN Guidelines for Patients: Melanoma, treatment approaches vary significantly based on your stage:

For earlier stages (0-3): Surgery is typically primary, sometimes with additional therapies like immunotherapy or targeted therapy designed to prevent recurrence.

For advanced/metastatic melanoma (stage 4): The NCCN Guidelines note that "more effective treatments have become available in the past decade for melanoma that has spread." Treatment options include:

• Immunotherapy (checkpoint inhibitors like nivolumab or pembrolizumab)
• Targeted therapy (if you have specific mutations like BRAF)
• Radiation therapy
• Palliative care - specialized medical care focused on comfort, symptom relief, and quality of life

An Important Point About "Quality of Life"

Palliative care isn't the same as stopping all treatment. According to NCCN Guidelines, palliative care can be combined with active treatment to manage symptoms and side effects while you're still receiving cancer-directed therapy. This means you don't have to choose between fighting the cancer and feeling well—you can often do both.

Questions to Ask Your Oncology Team

These questions will help you have a meaningful conversation about your options:

1. "Based on my specific stage and type of melanoma, what is the goal of my current treatment?" (Is it curative, to extend life, or to manage symptoms?)

2. "How is my cancer responding to treatment right now?" (This is crucial—response changes the calculus significantly)

3. "What are the realistic benefits and side effects of continuing my current treatment?"

4. "What does palliative care look like for me, and could it be combined with my current treatment?"

5. "If I decided to stop active treatment, what support would be available to manage my symptoms and maintain quality of life?"

6. "Can we discuss my personal values and goals to make sure my treatment plan aligns with what matters most to me?"

7. "Are there clinical trials available that might offer different options?" (The NCCN Guidelines emphasize that everyone with cancer should consider clinical trials)

What Shared Decision-Making Looks Like

The NCCN Guidelines emphasize that you have an important role in your care. This means:

• Your doctors should explain the reasoning behind recommendations
• You should understand the pros and cons of each option
• Your values and preferences should shape the final decision
• This is a conversation, not a one-way directive

A Compassionate Reality

Some people find that continuing treatment—even if it's challenging—aligns with their values and goals. Others find that focusing on comfort, time with loved ones, and symptom management becomes the priority. Both choices are valid. The key is making an informed decision that reflects what matters most to you.

---

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.

Sources: NCCN Guidelines for Patients: Melanoma, 2025